Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2018 1
2022 1
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban to prevent major clinical outcomes in non-hospitalised patients with COVID-19: the CARE - COALITION VIII randomised clinical trial.
Avezum Á, Oliveira Junior HA, Neves PDMM, Alves LBO, Cavalcanti AB, Rosa RG, Veiga VC, Azevedo LCP, Zimmermann SL, Silvestre OM, Seabra Prudente RC, Morales Kormann AP, Moreira FR, Boszczowski I, de Brito Sobrinho E, da Silva E Souza A, Seligman R, de Souza Paolino B, Razuk A, Diogenes de Magalhaes Feitosa A, Monteiro Belmonte PL, Freitas das Neves Gonçalves P, Hernandes ME, Fagundes AL, Sarmet Esteves JM, Tognon AP, Eikelboom J, Berwanger O, Lopes RD, Oliveira GBF; Coalition VIII COVID-19 Brazil Investigators. Avezum Á, et al. Among authors: oliveira junior ha. EClinicalMedicine. 2023 Jun;60:102004. doi: 10.1016/j.eclinm.2023.102004. Epub 2023 May 18. EClinicalMedicine. 2023. PMID: 37223666 Free PMC article.
Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis.
de Oliveira Ascef B, Almeida MO, de Medeiros-Ribeiro AC, de Oliveira Andrade DC, de Oliveira Junior HA, de Soárez PC. de Oliveira Ascef B, et al. Among authors: de oliveira junior ha. Sci Rep. 2023 Aug 22;13(1):13699. doi: 10.1038/s41598-023-40222-5. Sci Rep. 2023. PMID: 37607959 Free PMC article.
Forecasting models for leprosy cases: a scoping review protocol.
Oliveira Ascef B, de Oliveira GLA, Ribeiro Filha Coriolano C, De Oliveira Junior HA. Oliveira Ascef B, et al. Among authors: de oliveira junior ha. BMJ Open. 2022 Jul 28;12(7):e062828. doi: 10.1136/bmjopen-2022-062828. BMJ Open. 2022. PMID: 35902193 Free PMC article.
Mapping the characteristics, concepts and methodologies of matching-adjusted indirect comparison studies assessing pharmacological therapies in oncology: a scoping review protocol.
Farinasso CM, Rocha AP, Medeiros FC, Marra LP, Silva Parreira PC, Oliveira LA, Ferreira VL, Lucchetta RC, De Oliveira Junior HA. Farinasso CM, et al. Among authors: de oliveira junior ha. BMJ Open. 2023 Jul 19;13(7):e072156. doi: 10.1136/bmjopen-2023-072156. BMJ Open. 2023. PMID: 37474190 Free PMC article.
Application of ventilator-associated events (VAE) in ventilator-associated pneumonia (VAP) notified in Brazil (IMPACTO MR-PAV): a protocol for a cohort study.
Nascimento GM, Gomes Rodrigues DL, Mangas Catarino DG, Piastrelli FT, Cheno MY, Braz KCC, Oliveira Alves LB, Avezum Á, Veiga VC, Zavascki AP, Tomazini B, Besen B, Pereira AJ, Marques de Pinho APN, De Oliveira Junior HA. Nascimento GM, et al. Among authors: de oliveira junior ha. BMJ Open. 2023 Dec 9;13(12):e076047. doi: 10.1136/bmjopen-2023-076047. BMJ Open. 2023. PMID: 38070904 Free PMC article.
Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System (Sistema Único de Saúde), Minas Gerais, Brazil.
de Oliveira Junior HA, dos Santos JB, Acurcio FA, Almeida AM, Kakehasi AM, Alvares J, de Carvalho LF, Cherchiglia ML. de Oliveira Junior HA, et al. Expert Rev Pharmacoecon Outcomes Res. 2015 Jun;15(3):403-12. doi: 10.1586/14737167.2015.1003367. Epub 2015 Jan 20. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25603696